1. 10.5 Tissue engineering approach with acellular matrix supports affected diaphragm of an atrophic mouse model with activation of resident cells. (9th June 2014) Authors: Urbani, L; Piccoli, M; Alvarez Fallas, ME; Dedja, A; Magrofuoco, E; Elvassore, N; Franzin, C; Pozzobon, M; De Coppi, P Journal: Archives of disease in childhood Issue: Volume 99:Supplement 1(2014) Page Start: A16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2SPD-029 Stability of nivolumab solutions after transport through pneumatic tube systems. (23rd March 2022) Authors: Selmin, F; Camuffo, L; Vasile, F; Mangoni, G; Piccoli, M; Rivano, M; Cancanelli, L; Minghetti, P Journal: European journal of hospital pharmacy Issue: Volume 29(2022)Supplement 1 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3PC-015 Short term stability of diluted solutions of the monoclonal antibody daratumumab. (24th March 2020) Authors: Mangoni, G; Selmin, F; Camuffo, L; Cancanelli, L; Piccoli, M; Rivano, M; Cervi, L; Cilurzo, F; Minghetti, P Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3PC-016 Stability of compounded nivolumab solution after pneumatic system transportation. (24th March 2020) Authors: Camuffo, L; Selmin, F; Vasile, F; Rivano, M; Piccoli, M; Mangoni, G; Cancanelli, L; Fazio, M; Cilurzo, F; Minghetti, P Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3PC-021 Storage of nivolumab pembrolizumab and daratumumab for 14 days after compounding in the hospital pharmacy: a microbiological stability study. (24th March 2020) Authors: Cancanelli, L; Selmin, F; Camuffo, L; Mangoni, G; Piccoli, M; Rivano, M; Cilurzo, F; Minghetti, P Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 3PC-044 In use physicochemical stability of pembrolizumab under the dilution condition required for use in a day hospital. (24th March 2020) Authors: Piccoli, M; Selmin, F; Mangoni, G; Camuffo, L; Cancanelli, L; Rivano, M; Jemos, C; Cilurzo, F; Omodeo Salè, E Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 4CPS-193 Measuring the impact of hospital pharmacist prescription reviewing in an oncology setting on the pharmacovigilance reporting in a comprehensive cancer centre. (24th March 2020) Authors: Omodeo Salè, E; Pezzella, D; Piccoli, M; Milani, M; Jemos, C; Malengo, D; Carrara, F; Cimino, D Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 4CPS-194 The underreporting rate as a pharmacovigilance process indicator in a comprehensive cancer centre. (24th March 2020) Authors: Omodeo Salè, E; Pezzella, D; Piccoli, M; Milani, M; Jemos, C; Malengo, D; Carrara, F; Cimino, D Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 4CPS-233 Coverage of energy and protein needs in patients with kidney failure or liver failure receiving total parenteral nutrition. (2nd March 2018) Authors: Piccoli, M; Jemos, C; Milani, M; Pezzella, D; Mazzoleni, L; Salè, E Omodeo Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 5PSQ-117 Failure mode and effects criticality analysis: multicentric application on cancer chemotherapy process. (2nd March 2018) Authors: Milani, M; Jemos, C; Piccoli, M; Clerici, I; Maiolino, P; Boccia, R; Colosio, C; Ursini, CL; Tramontano, T; Lucchetti, E; Salè, E Omodeo Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗